Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in drug discovery, from novel targets and screening tools through to automation and computational chemistry

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
AI, Machine Learning & Computational Drug Design

AutoPrognosis, An Innovative Tool Used to Predict Lung Cancer Risk

Machine learning model paves the way for predicting lung cancer.
Read More
AI, Machine Learning & Computational Drug Design

From Theory to Therapy: Accelerating Ligand-Based Virtual Screening with AI and ML Technologies

Discover the transformative role of AI and ML in improving ligand-based virtual screening outcomes, from breakthrough drug candidate identification to overcoming challenges in data quality and computational resources
Read More
SmartLabs & Automation

Bruker Corp to buy Chemspeed in ramp-up of automation portfolio

Automation of laboratory workflows can improve the speed and efficiency of QC and R&D; the acquisition represents the development of Bruker’s entry into the field.
Read More
SmartLabs & Automation

Automation in Medicinal Chemistry: A Look at Synthesis Advances

Medicinal chemistry is rapidly advancing with the integration of automation technologies, which are revolutionizing the synthesis and development of new drugs by enhancing efficiency, precision, and creativity.
Read More
Neuroscience Discovery

University of Pennsylvania and FAST to Develop AAV Gene Therapy for Angelman Syndrome

The collaboration hopes to develop a AAV gene therapy for rare genetic disease Angelman syndrome.
Read More
Targeted Protein Degradation

Targeting Novel E3 Ubiquitin Ligases: Carles Galdeano, Professor, University of Barcelona

We discuss working on PROTACs, targeting novel E3 ubiquitin ligases, and Dr Galdeano's spin out Oniria Therapeutics.
Read More
Organ Modelling Discovery

Spheroids, Assembloids Could Unlock High Throughput Screening of Neuro Drugs

These spheroids can mimic different sections of the human brain based on their cell-type composition, and promisingly could enable high-throughput screening of neurology drugs.
Read More
Targeted Protein Degradation

Talking TPD with Ben Cross, CTO and Head of Platform at PhoreMost

Delving into PhoreMost's role in targeted protein degradation, the innovation behind the SITESEEKER platform, and the challenges and breakthroughs in the dynamic field of drug discovery.
Read More
Target Based Discovery

Pivot Park Screening Centre: We Help You to Accelerate Drug Discovery

Are you looking for lead candidate compounds for your target or cellular phenotype, and do you want your drug discovery program to be more efficient, both in terms of time and cost?
Read More
AI, Machine Learning & Computational Drug Design

Interview with Sridevi Nagarajan, Head Digital Regulatory Strategy at AstraZeneca

AstraZeneca’s Sridevi Nagarajan discusses the importance of artificial intelligence, strategic collaboration, and the role of the metaverse in unlocking the future of digital regulatory.
Read More
Pharma Data

Funding Opportunity Announced for Generating Real-World Evidence in Regulatory Decision-Making

The U.S. Food and Drug Administration (FDA) is encouraging pharmaceutical developers to submit real-world evidence in support of regulatory applications.
Read More
Organ Modelling Discovery

Vascular Organoids used to Model the Impact of COVID-19 on Circulation

Researchers have used vascular organoids to look at the impact of SARS-CoV-2 on blood circulation, which has led to the discovery of a potential therapeutic target.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery